Summary

Injectable Drug Delivery Market – Scope of Report
TMR’s report on the global injectable drug delivery market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global injectable drug delivery market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global injectable drug delivery market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the injectable drug delivery market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global injectable drug delivery market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global injectable drug delivery market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global injectable drug delivery market.

The report delves into the competitive landscape of the global injectable drug delivery market. Key players operating in the global injectable drug delivery market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global injectable drug delivery market profiled in this report.

Key Questions Answered in Global injectable drug delivery Market Report
• What is the sales/revenue generated by injectable drug delivery across all regions during the forecast period?
• What are the opportunities in the global injectable drug delivery market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Injectable Drug Delivery Market – Research Objectives and Research Approach
The comprehensive report on the global injectable drug delivery market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global injectable drug delivery market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global injectable drug delivery market.

ページTOPに戻る

Table of Contents

1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Injectable Drug Delivery Market
4. Market Overview
    4.1. Introduction
        4.1.1. Segment Definition
        4.1.2. Industry Evolution / Developments
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Injectable Drug Delivery Market Analysis and Forecasts, 2020-2034
        4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
    5.1. PEST Analysis
    5.2. Product Launches and Approvals
    5.3. Regulatory Landscape for Injectable Drug Delivery in Key Regions / Countries
    5.4. FDA Drug Approval Process
    5.5. Key Industry Events (Acquisition, Partnerships, And Collaborations)
6. Global Injectable Drug Delivery Market Analysis and Forecasts, By Product Type
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast By Product Type, 2020-2034
        6.3.1. Devices
            6.3.1.1. Conventional Injection Devices
            6.3.1.2. Self Injection Devices
            6.3.1.3. Others
        6.3.2. Formulations
            6.3.2.1. Conventional Drug Delivery Formulations
            6.3.2.2. Novel Drug Delivery Formulations
            6.3.2.3. Long Lasting Injection Formulations
    6.4. Market Attractiveness By Product Type
7. Global Injectable Drug Delivery Market Analysis and Forecasts, By Therapeutic Application
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast By Therapeutic Application, 2020-2034
        7.3.1. Autoimmune Disease
        7.3.2. Hormone Disease
        7.3.3. Orphan Disease
        7.3.4. Cancer
        7.3.5. Cardiovascular Disease
        7.3.6. Infectious Disease
        7.3.7. Others
    7.4. Market Attractiveness By Therapeutic Application
8. Global Injectable Drug Delivery Market Analysis and Forecasts, By Usage Pattern
    8.1. Introduction & Definition
    8.2. Key Findings / Developments
    8.3. Market Value Forecast By Usage Pattern, 2020-2034
        8.3.1. Curative Care
        8.3.2. Immunization
        8.3.3. Others
    8.4. Market Attractiveness By Usage Pattern
9. Global Injectable Drug Delivery Market Analysis and Forecasts, By End-user
    9.1. Introduction & Definition
    9.2. Key Findings / Developments
    9.3. Market Value Forecast By End-user, 2020-2034
        9.3.1. Hospitals and Clinics
        9.3.2. Ambulatory Surgical Centers
        9.3.3. Home Care Settings
        9.3.4. Others
    9.4. Market Attractiveness By End-user
10. Global Injectable Drug Delivery Market Analysis and Forecasts, By Region
    10.1. Key Findings
    10.2. Market Value Forecast By Region
        10.2.1. North America
        10.2.2. Europe
        10.2.3. Asia Pacific
        10.2.4. Latin America
        10.2.5. Middle East & Africa
    10.3. Market Attractiveness By Country/Region
11. North America Injectable Drug Delivery Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast By Product Type, 2020-2034
        11.2.1. Devices
            11.2.1.1. Conventional Injection Devices
            11.2.1.2. Self Injection Devices
            11.2.1.3. Others
        11.2.2. Formulations
            11.2.2.1. Conventional Drug Delivery Formulations
            11.2.2.2. Novel Drug Delivery Formulations
            11.2.2.3. Long Lasting Injection Formulations
    11.3. Market Value Forecast By Therapeutic Application, 2020-2034
        11.3.1. Autoimmune Disease
        11.3.2. Hormone Disease
        11.3.3. Orphan Disease
        11.3.4. Cancer
        11.3.5. Cardiovascular Disease
        11.3.6. Infectious Disease
        11.3.7. Others
    11.4. Market Value Forecast By Usage Pattern, 2020-2034
        11.4.1. Curative Care
        11.4.2. Immunization
        11.4.3. Others
    11.5. Market Value Forecast By End-user, 2020-2034
        11.5.1. Hospitals and Clinics
        11.5.2. Ambulatory Surgical Centers
        11.5.3. Home Care Settings
        11.5.4. Others
    11.6. Market Value Forecast By Country, 2020-2034
        11.6.1. U.S.
        11.6.2. Canada
    11.7. Market Attractiveness Analysis
        11.7.1. By Product Type
        11.7.2. By Therapeutic Application
        11.7.3. By Usage Pattern
        11.7.4. By End-user
        11.7.5. By Country
12. Europe Injectable Drug Delivery Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast By Product Type, 2020-2034
        12.2.1. Devices
            12.2.1.1. Conventional Injection Devices
            12.2.1.2. Self Injection Devices
            12.2.1.3. Others
        12.2.2. Formulations
            12.2.2.1. Conventional Drug Delivery Formulations
            12.2.2.2. Novel Drug Delivery Formulations
            12.2.2.3. Long Lasting Injection Formulations
    12.3. Market Value Forecast By Therapeutic Application, 2020-2034
        12.3.1. Autoimmune Disease
        12.3.2. Hormone Disease
        12.3.3. Orphan Disease
        12.3.4. Cancer
        12.3.5. Cardiovascular Disease
        12.3.6. Infectious Disease
        12.3.7. Others
    12.4. Market Value Forecast By Usage Pattern, 2020-2034
        12.4.1. Curative Care
        12.4.2. Immunization
        12.4.3. Others
    12.5. Market Value Forecast By End-user, 2020-2034
        12.5.1. Hospitals and Clinics
        12.5.2. Ambulatory Surgical Centers
        12.5.3. Home Care Settings
        12.5.4. Others
    12.6. Market Value Forecast By Country, 2020-2034
        12.6.1. Germany
        12.6.2. U.K.
        12.6.3. France
        12.6.4. Italy
        12.6.5. Spain
        12.6.6. Rest of Europe
    12.7. Market Attractiveness Analysis
        12.7.1. By Product Type
        12.7.2. By Therapeutic Application
        12.7.3. By Usage Pattern
        12.7.4. By End-user
        12.7.5. By Country
13. Asia Pacific Injectable Drug Delivery Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast By Product Type, 2020-2034
        13.2.1. Devices
            13.2.1.1. Conventional Injection Devices
            13.2.1.2. Self Injection Devices
            13.2.1.3. Others
        13.2.2. Formulations
            13.2.2.1. Conventional Drug Delivery Formulations
            13.2.2.2. Novel Drug Delivery Formulations
            13.2.2.3. Long Lasting Injection Formulations
    13.3. Market Value Forecast By Therapeutic Application, 2020-2034
        13.3.1. Autoimmune Disease
        13.3.2. Hormone Disease
        13.3.3. Orphan Disease
        13.3.4. Cancer
        13.3.5. Cardiovascular Disease
        13.3.6. Infectious Disease
        13.3.7. Others
    13.4. Market Value Forecast By Usage Pattern, 2020-2034
        13.4.1. Curative Care
        13.4.2. Immunization
        13.4.3. Others
    13.5. Market Value Forecast By End-user, 2020-2034
        13.5.1. Hospitals and Clinics
        13.5.2. Ambulatory Surgical Centers
        13.5.3. Home Care Settings
        13.5.4. Others
    13.6. Market Value Forecast By Country, 2020-2034
        13.6.1. China
        13.6.2. India
        13.6.3. Japan
        13.6.4. Australia & New Zealand
        13.6.5. Rest of Asia Pacific
    13.7. Market Attractiveness Analysis
        13.7.1. By Product Type
        13.7.2. By Therapeutic Application
        13.7.3. By Usage Pattern
        13.7.4. By End-user
        13.7.5. By Country
14. Latin America Injectable Drug Delivery Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast By Product Type, 2020-2034
        14.2.1. Devices
            14.2.1.1. Conventional Injection Devices
            14.2.1.2. Self Injection Devices
            14.2.1.3. Others
        14.2.2. Formulations
            14.2.2.1. Conventional Drug Delivery Formulations
            14.2.2.2. Novel Drug Delivery Formulations
            14.2.2.3. Long Lasting Injection Formulations
    14.3. Market Value Forecast By Therapeutic Application, 2020-2034
        14.3.1. Autoimmune Disease
        14.3.2. Hormone Disease
        14.3.3. Orphan Disease
        14.3.4. Cancer
        14.3.5. Cardiovascular Disease
        14.3.6. Infectious Disease
        14.3.7. Others
    14.4. Market Value Forecast By Usage Pattern, 2020-2034
        14.4.1. Curative Care
        14.4.2. Immunization
        14.4.3. Others
    14.5. Market Value Forecast By End-user, 2020-2034
        14.5.1. Hospitals and Clinics
        14.5.2. Ambulatory Surgical Centers
        14.5.3. Home Care Settings
        14.5.4. Others
    14.6. Market Value Forecast By Country, 2020-2034
        14.6.1. Brazil
        14.6.2. Mexico
        14.6.3. Rest of Latin America
    14.7. Market Attractiveness Analysis
        14.7.1. By Product Type
        14.7.2. By Therapeutic Application
        14.7.3. By Usage Pattern
        14.7.4. By End-user
        14.7.5. By Country
15. Middle East & Africa Injectable Drug Delivery Market Analysis and Forecast
    15.1. Introduction
        15.1.1. Key Findings
    15.2. Market Value Forecast By Product Type, 2020-2034
        15.2.1. Devices
            15.2.1.1. Conventional Injection Devices
            15.2.1.2. Self Injection Devices
            15.2.1.3. Others
        15.2.2. Formulations
            15.2.2.1. Conventional Drug Delivery Formulations
            15.2.2.2. Novel Drug Delivery Formulations
            15.2.2.3. Long Lasting Injection Formulations
    15.3. Market Value Forecast By Therapeutic Application, 2020-2034
        15.3.1. Autoimmune Disease
        15.3.2. Hormone Disease
        15.3.3. Orphan Disease
        15.3.4. Cancer
        15.3.5. Cardiovascular Disease
        15.3.6. Infectious Disease
        15.3.7. Others
    15.4. Market Value Forecast By Usage Pattern, 2020-2034
        15.4.1. Curative Care
        15.4.2. Immunization
        15.4.3. Others
    15.5. Market Value Forecast By End-user, 2020-2034
        15.5.1. Hospitals and Clinics
        15.5.2. Ambulatory Surgical Centers
        15.5.3. Home Care Settings
        15.5.4. Others
    15.6. Market Value Forecast By Country, 2020-2034
        15.6.1. GCC
        15.6.2. South Africa
        15.6.3. Rest of Middle East & Africa
    15.7. Market Attractiveness Analysis
        15.7.1. By Product Type
        15.7.2. By Therapeutic Application
        15.7.3. By Usage Pattern
        15.7.4. By End-user
        15.7.5. By Country
16. Competition Landscape
    16.1. Market Player - Competition Matrix (By Tier and Size of companies)
    16.2. Market Share Analysis By Company (2021)
    16.3. Market Footprint Analysis
        16.3.1. By Region
        16.3.2. By Product Type
    16.4. Competitive Business Strategies
    16.5. Company Profiles
        16.5.1. Market Player - Competition Matrix (By Tier and Size of Companies)
        16.5.2. Market Share Analysis, by Company (2023)
        16.5.3. Company Profiles
            16.5.3.1. Becton, Dickinson, and Company (BD)
                16.5.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                16.5.3.1.2. Product Portfolio
                16.5.3.1.3. Financial Overview
                16.5.3.1.4. SWOT Analysis
                16.5.3.1.5. Strategic Overview
            16.5.3.2. Pfizer, Inc.
                16.5.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                16.5.3.2.2. Product Portfolio
                16.5.3.2.3. Financial Overview
                16.5.3.2.4. SWOT Analysis
                16.5.3.2.5. Strategic Overview
            16.5.3.3. Eli Lilly and Company
                16.5.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                16.5.3.3.2. Product Portfolio
                16.5.3.3.3. Financial Overview
                16.5.3.3.4. SWOT Analysis
                16.5.3.3.5. Strategic Overview
            16.5.3.4. Baxter International, Inc.
                16.5.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                16.5.3.4.2. Product Portfolio
                16.5.3.4.3. Financial Overview
                16.5.3.4.4. SWOT Analysis
                16.5.3.4.5. Strategic Overview
            16.5.3.5. Terumo Corporation
                16.5.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                16.5.3.5.2. Product Portfolio
                16.5.3.5.3. Financial Overview
                16.5.3.5.4. SWOT Analysis
                16.5.3.5.5. Strategic Overview
            16.5.3.6. B. Braun Melsungen AG
                16.5.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                16.5.3.6.2. Product Portfolio
                16.5.3.6.3. Financial Overview
                16.5.3.6.4. SWOT Analysis
                16.5.3.6.5. Strategic Overview
            16.5.3.7. Ypsomed AG
                16.5.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                16.5.3.7.2. Product Portfolio
                16.5.3.7.3. Financial Overview
                16.5.3.7.4. SWOT Analysis
                16.5.3.7.5. Strategic Overview
            16.5.3.8. Gerresheimer AG
                16.5.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                16.5.3.8.2. Product Portfolio
                16.5.3.8.3. Financial Overview
                16.5.3.8.4. SWOT Analysis
                16.5.3.8.5. Strategic Overview
            16.5.3.9. SCHOTT Pharma
                16.5.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                16.5.3.9.2. Product Portfolio
                16.5.3.9.3. Financial Overview
                16.5.3.9.4. SWOT Analysis
                16.5.3.9.5. Strategic Overview
            16.5.3.10. Hi-Tech Syringes
                16.5.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                16.5.3.10.2. Product Portfolio
                16.5.3.10.3. Financial Overview
                16.5.3.10.4. SWOT Analysis
                16.5.3.10.5. Strategic Overview